ECSEL JU launches an “Expression of Vision” for their combined Call with IMI JU

Thumbnail

“Recent events have shown us the importance of both electronic components and systems and its support to the healthcare system.” Says Bert De Colvenaer, Executive Director of ECSEL JU. “We are happy, together with our sister JU IMI, to put our shoulders behind collaborative actions that can accelerate the way we provide valuable healthcare solutions for society. The ECSEL JU Call 3 for 2020 – conceived even before the present pandemic – is a concrete expression of this will to work together, and this ‘Expression of Vision’ is a vital first step in ensuring that this Call for Proposals can yield a project that brings maximum value to society.”

ECSEL JU is inviting potential candidate partners in projects for their Call 2020-3 to express their vision on how electronics technologies, in collaboration with an already ongoing project of IMI “Trials@Home” – can simplify and accelerate the essential clinical trials phase when introducing new treatments and drugs. Though not mandatory to participate in the Call, the inputs received though such expressions of vision can help greatly in calibrating realistic and practicable expectations on the projects selected from the Call for Proposals.

The deadline for sending in such Expressions of Vision for ECSEL JU Call-2020-3 is 24 April 2020 at 16:00 CET (Brussels time).  The one-stage ECSEL JU Call-2020-3 itself is expected to open on May 26th 2020, with provisional deadline September 30th. Proposers can expect to be informed about the funding decision in December 2020.

(Please find the Expression of Vision document here)

Further information about the IMI “Trials@Home” project can be found here:

https://www.imi.europa.eu/projects-results/project-factsheets/trialshome

https://www.imi.europa.eu/apply-funding/closed-calls/imi2-call-14

https://trialsathome.com

https://www.imi.europa.eu/news-events/newsroom/ecsel-ju-calls-input-planned-call-proposals-decentralised-clinical-trials